1. Home
  2. POOL vs VTRS Comparison

POOL vs VTRS Comparison

Compare POOL & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pool Corporation

POOL

Pool Corporation

HOLD

Current Price

$239.04

Market Cap

11.6B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$10.96

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POOL
VTRS
Founded
1993
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6B
12.0B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
POOL
VTRS
Price
$239.04
$10.96
Analyst Decision
Hold
Hold
Analyst Count
9
6
Target Price
$338.33
$11.17
AVG Volume (30 Days)
889.9K
7.9M
Earning Date
10-23-2025
11-06-2025
Dividend Yield
2.09%
4.39%
EPS Growth
N/A
N/A
EPS
10.93
N/A
Revenue
$5,294,666,000.00
$14,124,400,000.00
Revenue This Year
$1.92
N/A
Revenue Next Year
$3.55
$1.16
P/E Ratio
$21.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$229.63
$6.85
52 Week High
$380.82
$13.13

Technical Indicators

Market Signals
Indicator
POOL
VTRS
Relative Strength Index (RSI) 36.11 60.39
Support Level $240.31 $10.67
Resistance Level $251.73 $10.93
Average True Range (ATR) 7.22 0.24
MACD 2.23 0.01
Stochastic Oscillator 44.58 90.23

Price Performance

Historical Comparison
POOL
VTRS

About POOL Pool Corporation

Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: